Title of article :
Dolastatin 11 conformations, analogues and pharmacophore Original Research Article
Author/Authors :
Md. Ahad Ali، نويسنده , , Robert B. Bates، نويسنده , , Zackary D. Crane، نويسنده , , Christopher W. Dicus، نويسنده , , Michelle R. Gramme، نويسنده , , Ernest Hamel، نويسنده , , Jacob Marcischak، نويسنده , , David S. Martinez، نويسنده , , Kelly J. McClure، نويسنده , , Pichaya Nakkiew، نويسنده , , George R. Pettit، نويسنده , , Chad C. Stessman، نويسنده , , Bilal A. Sufi، نويسنده , , Gayle V. Yarick، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2005
Pages :
15
From page :
4138
To page :
4152
Abstract :
Twenty analogues of the natural antitumor agent dolastatin 11, including majusculamide C, were synthesized and tested for cytotoxicity against human cancer cells and stimulation of actin polymerization. Only analogues containing the 30-membered ring were active. Molecular modeling and NMR evidence showed the low-energy conformations. The amide bonds are all trans except for the one between the Tyr and Val units, which is cis. Since an analogue restricted to negative 2-3-4-5 angles stimulated actin polymerization but was inactive in cells, the binding conformation (most likely the lowest-energy conformation in water) has a negative 2–3–4–5 angle, whereas a conformation with a positive 2–3–4–5 angle (most likely the lowest energy conformation in chloroform) goes through cell walls. The highly active R alcohol from borohydride reduction of dolastatin 11 is a candidate for conversion to prodrugs.
Keywords :
depsipeptide , Anticancer , Pharmacophore , Dolastatin 11
Journal title :
Bioorganic and Medicinal Chemistry
Serial Year :
2005
Journal title :
Bioorganic and Medicinal Chemistry
Record number :
1304763
Link To Document :
بازگشت